The AHA, American Medical Association and American Nurses Association today applauded the recent decision by the Food and Drug Administration and Centers for Disease Control and Prevention to allow access to a Pfizer COVID-19 vaccine booster dose for nurses, physicians and others working in health care settings.

“We support every effort to protect the health and safety of those who are at higher risk for infection due to potential occupational exposure,” the organizations said in a joint statement. “At a time when our hospitals and health systems are seeing surging COVID-19 cases and as we ask our front-line health care professionals to continue to respond day-in and day-out, access to booster doses will provide an increase in protection. This action demonstrates a commitment to support health care professionals as they continue to care for patients in every community across the country. While COVID-19 vaccine effectiveness against severe disease remains high, health care professionals and other essential workers with even mild illness often cannot work. The agencies’ decision was based on emerging evidence that vaccine effectiveness against infection is waning among health care professionals, who received their vaccines early in the vaccination program, and a booster dose increases immune response. We look forward to data on the effectiveness and safety of Moderna and J&J booster shots in the coming weeks.

“We continue to urge nurses, physicians, all health care professionals, and the public to get vaccinated against COVID-19 and support consistently applied vaccination requirements for all those in the health care workforce. Collectively, these actions are necessary to help mitigate the impact of variants that continue to stall efforts to bring an end to this pandemic.”

 

Related News Articles

Headline
A mix-and-match vaccine regimen is permissible for international travelers entering the U.S., according to updated Centers for Disease Control and Prevention…
Headline
Treatment with subcutaneous interferon beta-1a plus remdesivir was not superior to treatment with remdesivir alone in a clinical trial that enrolled 969…
Headline
The Health Resources and Services Administration Oct. 21 will host the last in a series of webinar sessions on how to apply for a portion of $25.5 billion…
Headline
Two doses of the Pfizer vaccine are 93% effective at preventing COVID-19 hospitalization among children aged 12 to 18, according to a study at 19…
Blog
Everyone should feel safe in their workplace and community. Yet this often is not the case. Across the country we see acts of violence in all its forms – from…
Headline
A symposium hosted yesterday by the AHA at the HLTH conference featured a panel of experts discussing health transformation in the post-pandemic world.…